There are numerous definitions of polypharmacy to describe the use of many medications among older adults, but there is a need to clarify if they are purposive and meaningful. By means of a systematic review, we identified definitions of polypharmacy used in multimorbid older adults (≥65 years). We evaluated if the definitions align among the domains of research, clinical practice, and public health and appraised whether concepts of polypharmacy are based on strong foundations. More than 46 definitions of polypharmacy were retrieved from 348 publications (research: n = 243; clinical practice: n = 88; public health: n = 17). Several thresholds based on the number of medications were mentioned. The majority of the publications (n = 202, 58%) used a minimal threshold of five medications. Heterogeneous qualitative definitions were identified, mostly stating that polypharmacy is "more drugs than needed". There was no significant divergence between domains as to the type of definitions used, although qualitative definitions were more common in clinical practice. Nearly half (n = 156, 47%) of the publications provided no justification for the polypharmacy definition used. The wide variety of definitions for polypharmacy precludes comparisons, appropriate identification and management of polypharmacy in multimorbid older adults. Standardized definitions would allow more coherent judgments regarding the individual and collective stakes of polypharmacy.

Polypharmacy Definitions for Multimorbid Older Adults Need Stronger Foundations to Guide Research, Clinical Practice and Public Health / Sirois, Caroline; Domingues, Nelia Sofia; Laroche, Marie-Laure; Zongo, Arsène; Lunghi, Carlotta; Guénette, Line; Kröger, Edeltraut; Émond, Valérie. - In: PHARMACY. - ISSN 2226-4787. - ELETTRONICO. - 7:3(2019), pp. 126.1-126.14. [10.3390/pharmacy7030126]

Polypharmacy Definitions for Multimorbid Older Adults Need Stronger Foundations to Guide Research, Clinical Practice and Public Health

Lunghi, Carlotta
Membro del Collaboration Group
;
2019

Abstract

There are numerous definitions of polypharmacy to describe the use of many medications among older adults, but there is a need to clarify if they are purposive and meaningful. By means of a systematic review, we identified definitions of polypharmacy used in multimorbid older adults (≥65 years). We evaluated if the definitions align among the domains of research, clinical practice, and public health and appraised whether concepts of polypharmacy are based on strong foundations. More than 46 definitions of polypharmacy were retrieved from 348 publications (research: n = 243; clinical practice: n = 88; public health: n = 17). Several thresholds based on the number of medications were mentioned. The majority of the publications (n = 202, 58%) used a minimal threshold of five medications. Heterogeneous qualitative definitions were identified, mostly stating that polypharmacy is "more drugs than needed". There was no significant divergence between domains as to the type of definitions used, although qualitative definitions were more common in clinical practice. Nearly half (n = 156, 47%) of the publications provided no justification for the polypharmacy definition used. The wide variety of definitions for polypharmacy precludes comparisons, appropriate identification and management of polypharmacy in multimorbid older adults. Standardized definitions would allow more coherent judgments regarding the individual and collective stakes of polypharmacy.
2019
Polypharmacy Definitions for Multimorbid Older Adults Need Stronger Foundations to Guide Research, Clinical Practice and Public Health / Sirois, Caroline; Domingues, Nelia Sofia; Laroche, Marie-Laure; Zongo, Arsène; Lunghi, Carlotta; Guénette, Line; Kröger, Edeltraut; Émond, Valérie. - In: PHARMACY. - ISSN 2226-4787. - ELETTRONICO. - 7:3(2019), pp. 126.1-126.14. [10.3390/pharmacy7030126]
Sirois, Caroline; Domingues, Nelia Sofia; Laroche, Marie-Laure; Zongo, Arsène; Lunghi, Carlotta; Guénette, Line; Kröger, Edeltraut; Émond, Valérie
File in questo prodotto:
File Dimensione Formato  
Sirois et al. 2019_Pharmacy.pdf

accesso aperto

Tipo: Versione (PDF) editoriale
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione 475.58 kB
Formato Adobe PDF
475.58 kB Adobe PDF Visualizza/Apri
pharmacy-07-00126-s001.pdf

accesso aperto

Tipo: File Supplementare
Licenza: Licenza per Accesso Aperto. Altra tipologia di licenza compatibile con Open Access
Dimensione 633.01 kB
Formato Adobe PDF
633.01 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/844743
Citazioni
  • ???jsp.display-item.citation.pmc??? 29
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 37
social impact